Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
One-on-one interview
A type of qualitative research where a moderator asks questions to a single participant. This is opposed to group focus sessions, where a moderator asks questions to a group of people.
See also:
Focus groups
Focus group moderator
Data collection
Related terms
Quantitative research, Unstructured question, Response bias, Research and development (R&D), List price, Product differentiation, Adoption curve, Omnibus survey, Respondent, Coverage, Key opinion leader (KOL), Open ended question, Background, Ad concept testing, Strategic business unit (SBU),
COVID-19 Updates and Daily News
Featured jobs
-
Consultant Dermatologist (Freelance)
-
£110-180ph
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
-
Head of Health Psychology, London
-
Highly competitive salary
-
Senior Health Psychologist, London
-
Highly competitive salary
- Senior Account Executive, Medical/ Brand Communications, London
-
Highly competitive salary
- Recognising HIV Vaccine Awareness Day
- Boehringer Ingelheim’s pulmonary fibrosis treatment produces promising phase 2 data
- NICE recommends AstraZeneca’s Imfinzi for adults with non-small cell lung cancer
- Scientists discover new approach to treat brain tumours
- UICC launches global ATOM Coalition to increase access to essential cancer medicines
- Almirall and Evotec team up in multi-target dermatology alliance
- Sanofi and Regeneron receive FDA approval for eosinophilic oesophagitis treatment
- AstraZeneca’s COVID-19 vaccine receives EMA approval for use as third-dose booster
- Positive CHMP opinion issued for PTC Therapeutics’ Upstaza
- Live Webinar: The Future of MedTech: Streamlined Clinical Data Collection & Management
- Medscape: Connect to the conversation
- A Medscape 4-part video interview series
- J&J looks ahead at potential flu therapy after approval of its COVID-19 vaccine
- J&J appoints Thibaut Mongon as CEO designate of New Consumer Health Company
- MHRA approves Infex Therapeutics’s study for treatment for non-cystic fibrosis patients
- Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader
PMHub
Thrive Agency
We are a specialist health communication agency creating powerful and trusted content. If you’re looking for a partner to help...
